Indicators
| Number | Program performance indicator |
|---|---|
| Indicator 1 | Participation |
| Indicator 2 | Rescreening |
| Indicator 3 | Recall to assessment |
| Indicator 4 | Invasive breast cancer detection |
| Indicator 5 | Ductal carcinoma in situ detection |
| Indicator 6a | Interval cancers |
| Indicator 6b | Program sensitivity |
| Indicator 7a | Invasive breast cancer incidence |
| Indicator 7b | Ductal carcinoma in situ incidence |
| Indicator 8 | Mortality |
Source: BreastScreen Australia data dictionary: version 1.2. Cancer series no. 123. Cat. no. CAN 127. Canberra: AIHW.
|
Screening pathway |
Performance indicator |
|
|---|---|---|
|
Recruitment |
Indicator 1 |
Participation |
|
Indicator 2 |
Response to invitation |
|
|
Indicator 3 |
Rescreening |
|
|
Screening |
Indicator 4 |
Screening results |
|
Indicator 5 |
Correlation of screening results |
|
|
Screening HPV test performance |
Indicator 6 |
Screening HPV test positivity |
|
Indicator 7 |
Cervical cancer diagnosed after a low risk screening test result |
|
|
Indicator 8 |
Self-collection people positive for oncogenic HPV (not 16/18) who have an LBC test within 6 months |
|
|
Self-collection |
Indicator 9 |
Self-collection people positive for oncogenic HPV 16/18 who have a colposcopy within 6 months |
|
Indicator 10 |
Adherence to recommendation for follow-up |
|
|
Follow-up |
Indicator 11 |
Follow-up results |
|
Indicator 12 |
Colposcopy rate |
|
|
Assessment |
Indicator 13 |
Time to colposcopy |
|
Indicator 14 |
Biopsy rate |
|
|
Indicator 15 |
Yield of high-grade abnormalities on biopsy among people who attend colposcopy with higher risk screening results |
|
|
Indicator 16 |
Positive predictive value of colposcopy |
|
|
Indicator 17a |
High-grade cervical abnormality detection rate |
|
|
Diagnosis |
Indicator 17b |
Cervical cancer detection rate |
|
Indicator 18 |
Cervical cancers diagnosed by time since last screen |
|
|
Outcomes |
Indicator 19 |
Incidence of cervical cancer |
|
Indicator 20 |
Mortality from cervical cancer |
|
Source: Table 5.1 (pg 226) from the National Cervical Screening Program Data Dictionary: Version 1.1
-
AHPF Indicator: Cancer screening rates
Participation rates for the National Bowel Cancer Screening Program, Breastscreen Australia and the National Cervical Screening Program. Available data: National - State & Territory - Primary Health Network